Fell, Millie
Fell, Millie was paid $94K by Medicaid between Jan 2018 and Nov 2024, across 11 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 55% of everything it billed.
33Billing provider infoFELL, MILLIE
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1780607192assigned 07/26/2006
33bProvider typeSpecialist
28Total paid$94K
24GClaims6,301
24DCodes billed11
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#489 of 1,221
Median peer was paid$45K
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 562 | $9K | |
| 2019 | 755 | $14K | |
| 2020 | 848 | $14K | |
| 2021 | 1,582 | $26K | |
| 2022 | 1,073 | $16K | |
| 2023 | 827 | $9K | |
| 2024incomplete | 654 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 55% | 2,332 | 2,303 | $52K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 15% | 760 | 709 | $14K |
| 92250 | 13% | 1,025 | 983 | $12K | |
| 92134 | 7.6% | 1,697 | 1,639 | $7K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3.4% | 67 | 67 | $3K |
| 67028 | Intravitreal injection of a pharmacologic agent | 3.2% | 120 | 115 | $3K |
| 92133 | 2.1% | 177 | 171 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 43 | 41 | $313.62 |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 12 | 12 | $313.22 |
| 92083 | <1% | 12 | 12 | $312.48 | |
| 92145 | <1% | 56 | 56 | $212.33 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.